Skip to main content

Chien Jennifer's Form 4 filing

Rhythm Pharmaceuticals, Inc. (RYTM) · filed Aug 14, 2026

Accession no.
0001649904-26-000009
Filed
Aug 14, 2026, 7:04 PM ET
Trade date
Aug 13, 2026
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $8.90M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Chien JenniferCIK 0001801372Officer (EVP, Head of North America)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 13, 2026Common StockMOption exerciseAcquired+35,000$24.29+$850,15054,233Direct
Aug 13, 2026Common StockMOption exerciseAcquired+21,601$6.80+$146,886.875,834Direct
Aug 13, 2026Common StockSSaleDisposed−75,834$117.38−$8,901,531.420Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 13, 2026Common StockMOption exerciseDisposed−35,000$0.00$036,283Direct
Aug 13, 2026Common StockMOption exerciseDisposed−21,601$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)